F18.11

Clinical Causes: Peer pressure and social influences encouraging experimentation with inhalants Curiosity during adolescence or young adulthood Availability of inhalant substances in the environment, such as household products Underlying mental health issues such as depression or anxiety Previous history of substance abuse or addiction Lack of awareness about the dangers of inhalant use Environmental factors including family dynamics and socio-economic status

Key Symptoms: Euphoric sensations or dizziness when inhaling vapors Slurred speech or difficulty articulating Impaired coordination and lack of balance Mood swings or behavioral changes Nausea or vomiting during use Headaches or dizziness following inhalant exposure Possible signs of respiratory issues, such as coughing or nasal irritation

Diagnosis Path: Diagnosing inhalant use disorder involves a comprehensive clinical assessment. Healthcare providers typically evaluate the patient's history of inhalant use, frequency, and circumstances. Physical examinations and laboratory tests, including urine drug screens, may be used to detect recent inhalant exposure. Mental health evaluations help determine if there are co-occurring conditions. The diagnosis of 'in remission' is made when the individual has abstained from the substance for a specified duration, and there are no active symptoms of abuse or dependence.

Treatment Protocols: Managing inhalant use disorder in remission focuses on supporting sustained recovery and preventing relapse. Key approaches include: - Psychoeducation about the risks of inhalant use - Behavioral therapies such as cognitive-behavioral therapy (CBT) to address underlying issues - Developing coping strategies for cravings and triggers - Support groups and community resources to foster ongoing sobriety - Monitoring and follow-up care with healthcare professionals While no specific medication is approved for inhalant use disorder, addressing co-occurring mental health conditions can be beneficial. Regular ongoing support and early intervention at signs of relapse are vital components of effective management.